20/20 BioLabs, Inc. said President and Chief Executive Officer Jonathan Cohen and Chief Financial Officer Alan Bergman will meet institutional investors at the Maxim Growth Summit 2026 on October 13 and 14, 2026, at the Hard Rock Hotel New York, with the healthcare program scheduled for October 14. Additional meetings are planned in New York that week. The company develops AI-powered, laboratory-based blood tests for early detection and prevention of cancers and chronic diseases, including OneTest for Cancer, a multi-cancer early detection (MCED) blood test, and OneTest for Longevity, which measures inflammatory biomarkers and is commercially available. Its tests can be collected at home using upper-arm capillary devices and are processed at the company’s CAP-accredited and CLIA-licensed laboratory in Gaithersburg, Maryland.